Physical and functional testing of medical devices
Understanding the Pros and Cons of Utilising an Established Combinational Product Platform vs a Unique Combinational Product Platform when developing your product for market.
Identifying the various challenges and advantages from each scenario including Regulatory expectations regarding Physical and Functional Testing and how that may impact timelines and cost balancing speed to market against product differentiators
FACILITATED BY
DAVID TUDBURY | Europe Vice President, Medical Device Testing Division | Smithers
PANELLISTS INCLUDE
ALEX COLE | Head Of Strategic Marketing | CPI
MICHAEL KIPPING | Director, Medical Technologies – EMEAA | Element Materials Technology
GARETH WYNNE | Director of Medical Device Physical Testing Operations | Smithers
BRENNAN MILES | Managing Consultant – Head of Drug Delivery | Team Consulting
ANDREAS MELINIOTIS | Director of Device Development | Vectura Group plc.